Report of a bi-allelic truncating germline mutation in TP53

Natasha J Brown, Kanika Bhatia, Julie Teague, Susan M White, Patrick Lo, Jackie Challis, Victoria Beshay, Michael Sullivan, David Malkin, Jordan R Hansford

Research output: Contribution to journalArticlepeer-review

6 Citations (Scopus)

Abstract

The TP53 gene is fundamental to genomic integrity, cell cycle regulation, and apoptosis; it is the most commonly mutated gene in human cancer. Heterozygous germline mutations cause the autosomal dominant cancer predisposition syndrome, Li-Fraumeni Syndrome. Homozygous germline TP53 mutations in humans are rare. We report an infant from a consanguineous family who presented with synchronous malignancies. Remarkably, he carries a homozygous germline TP53 mutation (NM_000546.4:c.52delA), predicted to cause protein truncation. The family history is consistent with Li-Fraumeni syndrome.

Original languageEnglish
Pages (from-to)101-104
Number of pages4
JournalFamilial cancer
Volume18
Issue number1
DOIs
Publication statusPublished or Issued - Jan 2019
Externally publishedYes

Keywords

  • Carcinoma/diagnostic imaging
  • Choroid Plexus Neoplasms/diagnostic imaging
  • Consanguinity
  • Germ-Line Mutation
  • Homozygote
  • Humans
  • Infant
  • Li-Fraumeni Syndrome/genetics
  • Magnetic Resonance Imaging
  • Male
  • Neoplasms, Multiple Primary/diagnostic imaging
  • Orbital Neoplasms/diagnostic imaging
  • Pedigree
  • Rhabdomyosarcoma, Embryonal/diagnostic imaging
  • Tumor Suppressor Protein p53/genetics

Cite this